Brief: Satsuma Pharmaceuticals Posts Q2 Loss Per Share Of $0.65
11/08/2020 21:53
Aug 11 (Reuters) - Satsuma Pharmaceuticals Inc STSA.O :
* Q2 LOSS PER SHARE $0.65
* BELIEVES IT HAS SUFFICIENT FINANCIAL RESOURCES TO FUND
OPERATIONS THROUGH END OF 2021
* AS OF JUNE 30, 2020, COMPANY HAD $93.7 MILLION OF CASH,
CASH
EQUIVALENTS AND MARKETABLE SECURITIES
* Q2 EARNINGS PER SHARE VIEW $-0.71 -- REFINITIV IBES DATA
Source: (https://bit.ly/2XRnv2Y)
Further company coverage: STSA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Satsuma Pharmaceuticals
See all newsBrief: Satsuma Pharmaceuticals Announces FDA Acceptance Of 505(B)(2) NDA For Sts101, A Novel And Investigational Dihydroergotamine Nasal Powder Product For The Acute Treatment Of Migraine
Commencement Of Tender Offer For Satsuma Pharmaceuticals, Inc In U.S.
Brief: Satsuma Pharmaceuticals Says Received Letter Notifying Co Regained Compliance With Nasdaq
U.S. STOCKS ON THE MOVE-Alphabet Inc, BlackRock, Moderna
Satsuma Pharma soars on buyout deal from Japan's Shin Nippon